The role of low-income and middle-income country prisons in eliminating hepatitis C.
作者信息
Akiyama Matthew J, Kronfli Nadine, Cabezas Joaquin, Sheehan Yumi, Scheibe Andrew, Brahni Taha, Naik Kunal, Mashabela Pelmos, Chan Polin, Luhmann Niklas, Lloyd Andrew R
机构信息
Department of Medicine, Divisions of General Internal Medicine and Infectious Diseases, Albert Einstein College of Medicine/Montefiore Medical Center, New York 10467, NY, USA.
Department of Medicine, Division of Infectious Diseases and Chronic Viral Illness Service, McGill University, Montreal, QC, Canada.
出版信息
Lancet Public Health. 2022 Jul;7(7):e578-e579. doi: 10.1016/S2468-2667(22)00119-0.
Abstract
摘要
相似文献
1
The role of low-income and middle-income country prisons in eliminating hepatitis C.低收入和中等收入国家监狱在消除丙型肝炎方面的作用。
Lancet Public Health. 2022 Jul;7(7):e578-e579. doi: 10.1016/S2468-2667(22)00119-0.
2
Hepatitis C testing, treatment and prevention in low- and middle-income country prisons.中低收入国家监狱中的丙型肝炎检测、治疗和预防。
Nat Rev Gastroenterol Hepatol. 2022 Aug;19(8):484-485. doi: 10.1038/s41575-022-00645-3.
3
Dealing with the problem of hepatitis C in prisons.应对监狱中的丙型肝炎问题。
Aust N Z J Public Health. 1998 Jun;22(4):517-8. doi: 10.1111/j.1467-842x.1998.tb01428.x.
4
A retro disease on the loose. Rise of hepatitis C in prisons may fuel outbreak in general population.一种正在蔓延的复古疾病。监狱中丙型肝炎病例增加可能会引发普通人群中的疫情爆发。
Mod Healthc. 2005 Apr 25;35(17):34.
5
The Importance of Prisons in Achieving Hepatitis C Elimination: Insights from the Australian Experience.监狱在实现丙型肝炎消除方面的重要性：来自澳大利亚经验的见解。
Viruses. 2022 Feb 28;14(3):497. doi: 10.3390/v14030497.
6
Hepatitis C in European prisons: a call for an evidence-informed response.欧洲监狱中的丙型肝炎：呼吁基于证据的应对措施。
BMC Infect Dis. 2014;14 Suppl 6(Suppl 6):S17. doi: 10.1186/1471-2334-14-S6-S17. Epub 2014 Sep 19.
7
Is HCV elimination possible in prison?监狱中有可能消除丙型肝炎病毒吗？
Rev Esp Sanid Penit. 2017 Dec;19(3):70-73. doi: 10.4321/S1575-06202017000300001.
8
Prison puzzle: treating hepatitis C.监狱难题：治疗丙型肝炎
CMAJ. 2012 Jun 12;184(9):1017-8. doi: 10.1503/cmaj.109-4191. Epub 2012 May 7.
9
Hepatitis B, hepatitis C, and HIV in correctional populations: a review of epidemiology and prevention.惩教人群中的乙型肝炎、丙型肝炎和艾滋病毒：流行病学与预防综述
AIDS. 2005 Oct;19 Suppl 3:S41-6. doi: 10.1097/01.aids.0000192069.95819.aa.
10
People living in prison must be included in country monitoring systems to accurately assess HCV elimination progress.必须将监狱中的服刑人员纳入国家监测系统，以准确评估丙型肝炎病毒消除进展情况。
Lancet Gastroenterol Hepatol. 2024 Jun;9(6):500-501. doi: 10.1016/S2468-1253(24)00075-X.
引用本文的文献
1
Hepatitis C Virus: Epidemiological Challenges and Global Strategies for Elimination.丙型肝炎病毒：流行病学挑战与全球消除策略
Viruses. 2025 Jul 31;17(8):1069. doi: 10.3390/v17081069.
2
Tuberculosis treatment outcomes after transfer or release from incarceration: A retrospective cohort study from Brazil.监禁转移或释放后的结核病治疗结果：来自巴西的一项回顾性队列研究。
medRxiv. 2025 Apr 20:2025.04.19.25325982. doi: 10.1101/2025.04.19.25325982.
3
Feasibility of implementing viral hepatitis services into a correctional service facility in Cape Town, South Africa.在南非开普敦的一个惩教服务设施中实施病毒性肝炎服务的可行性。
Int J Drug Policy. 2025 Mar;137:104710. doi: 10.1016/j.drugpo.2025.104710. Epub 2025 Jan 23.
4
5
Impact of the COVID-19 pandemic on hepatitis C virus screening in provincial prisons in Montreal, Quebec, Canada.加拿大魁北克省蒙特利尔省监狱内 COVID-19 大流行对丙型肝炎病毒筛查的影响。
Front Public Health. 2024 Jul 23;12:1380126. doi: 10.3389/fpubh.2024.1380126. eCollection 2024.
6
DNA-directed formation of plasmonic core-satellite nanostructures for quantification of hepatitis C viral RNA.用于丙型肝炎病毒RNA定量的基于DNA导向的等离子体核-卫星纳米结构的形成。
Chem Sci. 2024 Apr 22;15(21):8112-8126. doi: 10.1039/d4sc00891j. eCollection 2024 May 29.
7
Barriers and advocacy needs for hepatitis C services in prisons: Informing the prisons hepatitis C advocacy toolkit.监狱丙型肝炎服务的障碍与宣传需求：为监狱丙型肝炎宣传工具包提供信息
Int J Drug Policy. 2024 Apr;126:104386. doi: 10.1016/j.drugpo.2024.104386. Epub 2024 Mar 15.
本文引用的文献
1
Hepatitis C elimination among people incarcerated in prisons: challenges and recommendations for action within a health systems framework.在监狱中关押人群中消除丙型肝炎：在卫生系统框架内采取行动的挑战和建议。
Lancet Gastroenterol Hepatol. 2021 May;6(5):391-400. doi: 10.1016/S2468-1253(20)30365-4.
2
Global Epidemiology of Viral Hepatitis.全球病毒性肝炎流行病学。
Gastroenterol Clin North Am. 2020 Jun;49(2):179-189. doi: 10.1016/j.gtc.2020.01.001.
3
The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study.全球、区域和国家级别的注射吸毒对丙型肝炎病毒传播的贡献：一项建模研究。
Lancet Gastroenterol Hepatol. 2019 Jun;4(6):435-444. doi: 10.1016/S2468-1253(19)30085-8. Epub 2019 Apr 10.
4
Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis.监禁史与注射吸毒人群中 HIV 和丙型肝炎病毒感染风险：系统评价和荟萃分析。
Lancet Infect Dis. 2018 Dec;18(12):1397-1409. doi: 10.1016/S1473-3099(18)30469-9. Epub 2018 Oct 29.
5
Hepatitis C virus treatment as prevention in an extended network of people who inject drugs in the USA: a modelling study.美国扩大的注射吸毒者网络中丙型肝炎病毒治疗作为预防措施：一项建模研究。
Lancet Infect Dis. 2018 Feb;18(2):215-224. doi: 10.1016/S1473-3099(17)30676-X. Epub 2017 Nov 15.
6
Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees.全球囚犯和被拘留者中的艾滋病毒、病毒性肝炎和结核病负担。
Lancet. 2016 Sep 10;388(10049):1089-1102. doi: 10.1016/S0140-6736(16)30466-4. Epub 2016 Jul 14.
Zotero 插件